39741-46-3

Basic information

• Product Name: 3-BROMO-5-(CHLOROMETHYL)PYRIDINE HYDROCHLORIDE
• Synonyms: 3-Bromo-5-(chloromethyl)pyridine hydrochloride 95%
• CAS NO: 39741-46-3
• Molecular Formula: C₆H₅BrClN*ClH
• Molecular Weight: 0
• Product Categories: Heterocycle-Pyridine series
• Mol File: 39741-46-3.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 298.3°Cat760mmHg
• Flash Point: 134.2°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 0.000958mmHg at 25°C
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: 3-BROMO-5-(CHLOROMETHYL)PYRIDINE HYDROCHLORIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BROMO-5-(CHLOROMETHYL)PYRIDINE HYDROCHLORIDE(39741-46-3)
• EPA Substance Registry System: 3-BROMO-5-(CHLOROMETHYL)PYRIDINE HYDROCHLORIDE(39741-46-3)

Safety Data

• Hazard Codes: C
• Hazardous Substances Data: 39741-46-3(Hazardous Substances Data)

Usage

General Description

3-Bromo-5-(chloromethyl)pyridine hydrochloride is a chemical compound with the molecular formula C6H5BrClN2. It is a yellowish-white crystalline powder that is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. 3-BROMO-5-(CHLOROMETHYL)PYRIDINE HYDROCHLORIDE is also used in the production of dyes and other organic compounds. It is a halogenated pyridine derivative with both bromine and chlorine substituents, making it useful in a variety of chemical reactions. The hydrochloride salt form makes it more water soluble and thus more readily usable in aqueous environments. However, it is important to handle this compound with caution as it can be harmful if it comes into contact with skin, eyes, or if ingested or inhaled.

InChI:InChI=1/C6H5BrClN.ClH/c7-6-1-5(2-8)3-9-4-6;/h1,3-4H,2H2;1H

Upstream product

• 113118-81-3 5-bromopyridine-3-carbaldehyde 
• 22620-36-6 3-bromo-5-(hydroxymethyl)pyridine hydrochloride 
• 37669-64-0 (5-bromopyridin-3-yl)methanol 
• 29681-44-5 5-bromo-3-pyridine carboxylic acid methyl ester 
• 20826-04-4 5-bromo-3-pyridinecarboxylic acid 

Downstream Products

• 1332502-86-9 2-[(5-bromopyridin-3-yl)methyl]-5-(4-chlorophenyl)-4-[(2S)-3,3,3-trifluoro-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one 
• 1332502-85-8 2-[(5-bromopyridin-3-yl)methyl]-5-(4-chlorophenyl)-4-(3,3,3-trifluoro-2-hydroxypropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one 
• 1255870-19-9 2-chloro-4-[5-(1,1-dioxo-isothiazoiidin-2-ylmethyl)-pyridin-3-yl]-benzonitrile 
• 919347-14-1 [2-(methyloxy)ethyl]{[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-pyridinyl]methyl}amine 
• 908864-98-2 1-(5-bromopyridin-3-yl)-N,N-dimethylmethanamine 
• 1246034-49-0 [(5-bromo-3-pyridinyl)methyl][2-(methyloxy)ethyl]amine 
• 364793-91-9 4-((5-bromopyridin-3-yl)methyl)morpholine 
• 166094-31-1 3-(N,N-dimethylthiocarbamoyl)-5-(2-tert-butyldiphenylsilyloxyethoxymethyl)pyridine 
• 166094-28-6 3-(N,N-dimethylcarbamoyl)-5-(2-tert-butyldiphenylsilyloxyethoxymethyl)pyridine 
• 166094-30-0 3-(N-methylthiocarbamoyl)-5-(2-tert-butyldiphenylsilyloxyethoxymethyl)pyridine 
• 166094-22-0 5-(2-tert-butyldiphenylsilyloxyethoxymethyl)-3-methoxycarbonylpyridine 
• 166094-27-5 3-(N-methylcarbamoyl)-5-(2-tert-butyldiphenylsilyloxyethoxymethyl)pyridine 
• 166094-29-7 3-thiocarbamoyl-5-(2-tert-butyldiphenylsilyloxyethoxymethyl)pyridine 
• 166094-26-4 3-carbamoyl-5-(2-tert-butyldiphenylsilyloxyethoxymethyl)pyridine 

Relevant articles and documents

METHODS OF USING INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/B-CATENIN SIGNALING PATHWAY INHIBITORS

This disclosure features the use of one or more indazole-3-carboxamide compounds or salts or analogs thereof, in the treatment of one or more diseases or conditions independently selected from the group consisting of a tendinopathy, dermatitis, psoriasis, morphea, ichthyosis, Raynaud's syndrome, and Darier's disease; and/or for promoting wound healing. The methods include administering to a subject (e.g., a subject in need thereof) a therapeutically effective amount of one or more indazole-3-carboxamide compounds or salts or analogs thereof as described anywhere herein.

ALDOSTERONE SYNTHASE INHIBITORS

This invention relates to tricyclic triazole analogues of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.

Amide compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use

Amide compounds that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds, and to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis, by administering effective amounts of such compounds.